Nucleus Network Pty Ltd

Running trials

• Not yet recruiting

  DDI Study of ECC0509 With Metformin, Midazolam, and Caffeine

  NCT07873229· Phase 1· Source

• Not yet recruiting

  A Study of SYH2092 Injection in Healthy Participants

  NCT07776041· Phase 1· Source

• Not yet recruiting

  A Study of GSM-779690T in Healthy Adult Participants

  NCT07690228· Phase 1· Source

• Recruiting

  Study of ECC4703 With Sulfasalazine and Pitavastatin

  NCT07726368· Phase 1· Source

• Recruiting

  A Study of HL40626S Tablets in Healthy Adults

  NCT07736586· Phase 1· Source

• Not yet recruiting

  A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants.

  NCT07724431· Phase 1· Source

• Recruiting

  A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969

  NCT07581431· Phase 1· Source

• Recruiting

  Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers

  NCT07347678· Phase 1· Source

• Recruiting

  Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity

  NCT07245771· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity4 recruiting
• Alzheimer disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Psoriasis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Phase 1b Study to Evaluate the Safety of XEN-101

  NCT06417697· Phase 1· Source

• Completed

  A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

  NCT06213844· Phase 1· Source

• Completed

  Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants

  NCT06206811· Phase 1· Source

• Completed

  JX09 SAD/MAD in Healthy Participants

  NCT06183671· Phase 1· Source

• Completed

  A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)

  NCT05975047· Phase 1· Source

• Completed

  Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

  NCT05814107· Phase 1· Source

• Completed

  A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women

  NCT05225857· Phase 1· Source

• Completed

  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

  NCT04242199· Phase 1· Source